RxDoctor Payments Data

Kathryn Wilt

Adult Health · Louisville, KYNPI 1134422751

Payments from drug & device makers

$738in general payments, 2019–2025

Across 42 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$245
  • Vifor Pharma, Inc.$78
  • Daiichi Sankyo Inc.$57
  • Otsuka America Pharmaceutical, Inc.$55
  • GSK$51
  • OPKO Pharmaceuticals, LLC$38
  • plus $214 from 10 others

What the payments were for

  • Food & beverage$70095%
  • Education$385%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$738 in reported general payments places this provider in the 55th percentile of 170 adult health providers in Kentucky.

See all adult health providers in Kentucky

Medicare billing

Part B allowed, 2024
$24,210
Medicare patients
161
Services billed
444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol14$8,881
SynthroidLevothyroxine Sodium12$977
Amlodipine Besylate80$550
Calcitriol23$323
Levothyroxine Sodium35$304
Metoprolol Succinate18$296
Rosuvastatin Calcium18$283
Gabapentin22$269
Losartan Potassium42$224
Lisinopril32$205
Atorvastatin Calcium23$194
Trazodone Hcl36$193
Pantoprazole Sodium11$192
Furosemide43$158
Pravastatin Sodium11$139

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$245$8,88114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 170 adult health providers in Kentucky.

Other adult health in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →